Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 18;11(10):2819.
doi: 10.3390/biomedicines11102819.

Characterisation of Ferritin-Lymphocyte Ratio in COVID-19

Affiliations

Characterisation of Ferritin-Lymphocyte Ratio in COVID-19

Alexander Liu et al. Biomedicines. .

Abstract

Introduction: The ferritin-lymphocyte ratio (FLR) is a novel inflammatory biomarker for the assessment of acute COVID-19 patients. However, the prognostic value of FLR for predicting adverse clinical outcomes in COVID-19 remains unclear, which hinders its clinical translation. Methods: We characterised the prognostic value of FLR in COVID-19 patients, as compared to established inflammatory markers. Results: In 217 study patients (69 years [IQR: 55-82]; 60% males), FLR was weakly correlated with CRP (R = 0.108, p = 0.115) and white cell count (R = -0.144; p = 0.034). On ROC analysis, an FLR cut-off of 286 achieved a sensitivity of 86% and a specificity of 30% for predicting inpatient mortality (AUC 0.60, 95% CI: 0.53-0.67). The negative predictive values of FLR for ruling out mortality, non-invasive ventilation requirement and critical illness (intubation and/or ICU admission) were 86%, 85% and 93%, respectively. FLR performed similarly to CRP (AUC 0.60 vs. 0.64; p = 0.375) for predicting mortality, but worse than CRP for predicting non-fatal outcomes (all p < 0.05). On Kaplan-Meier analysis, COVID-19 patients with FLR values > 286 had worse inpatient survival than patients with FLR ≤ 286, p = 0.041. Conclusions: FLR has prognostic value in COVID-19 patients, and appears unrelated to other inflammatory markers such as CRP and WCC. FLR exhibits high sensitivity and negative predictive values for adverse clinical outcomes in COVID-19, and may be a good "rule-out" test. Further work is needed to improve the sensitivity of FLR and validate its role in prospective studies for guiding clinical management.

Keywords: C-reactive protein; coronavirus disease 19; ferritin–lymphocyte ratio; inflammatory biomarkers; risk stratification; white cell count.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Distribution of ferritin–lymphocyte (FLR) and other inflammatory markers. Panel (A): the numbers of patients in each FLR range are indicated above the bars; the inset shows distribution of FLR values between 0 and 5000. Panels (B,C) demonstrate the distribution of C-reactive protein (CRP) and white cell count (WCC) levels, respectively.
Figure 2
Figure 2
Correlations of ferritin–lymphocyte ratio (FLR) with CRP (Panel (A)) and WCC (Panel (B)). Each point represents data from a single patient. Pearson’s correlation co-efficient (R) values as indicated. CRP: C-reactive protein; WCC: white cell count.
Figure 3
Figure 3
Comparison of the prognostic value of ferritin–lymphocyte ratio (FLR) with other inflammatory markers. Receiver operator characteristics (ROC) curves are shown for predicting inpatient mortality (Panel (A)), requirement for non-invasive ventilation (Panel (B)) and critical illness, as defined by a composite of intubation, mechanical ventilation or intensive care unit admission (Panel (C)). AUC: area under the ROC curve; CRP: C-reactive protein; WCC: white cell count.
Figure 4
Figure 4
Kaplan–Meier analysis of inpatient survival based on ferritin–lymphocyte ratio (FLR). The optimal FLR threshold (286) was derived from receiver operating characteristics curves.

References

    1. Singh P., Warren K., Adler H., Mangano A., Sansbury J., Duff R. A Retrospective Review of Outcomes in Intensive Care Unit Patients Infected With SARS-Cov2 in Correlation to Admission Acute Physiologic Assessment and Chronic Health Evaluation II Scores. Cureus. 2021;13:e14051. doi: 10.7759/cureus.14051. - DOI - PMC - PubMed
    1. Botoș I.D., Pantiș C., Bodolea C., Nemes A., Crișan D., Avram L., Negrău M.O., Hirișcău I.E., Crăciun R., Puia C.I. The Dynamics of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict Progression to Septic Shock and Death in Patients with Prolonged Intensive Care Unit Stay. Medicina. 2022;59:32. doi: 10.3390/medicina59010032. - DOI - PMC - PubMed
    1. Kosidło J.W., Wolszczak-Biedrzycka B., Matowicka-Karna J., Dymicka-Piekarska V., Dorf J. Clinical Significance and Diagnostic Utility of NLR, LMR, PLR and SII in the Course of COVID-19: A Literature Review. J. Inflamm. Res. 2023;16:539–562. doi: 10.2147/JIR.S395331. - DOI - PMC - PubMed
    1. Mayne K.J., Lees J.S., Rutherford E., Thomson P.C., Traynor J.P., Dey V., Lang N.N., Mark P.B. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: Associations with mortality in a haemodialysis cohort. Clin. Kidney J. 2023;16:512–520. doi: 10.1093/ckj/sfac248. - DOI - PMC - PubMed
    1. Liu A., Hammond R., Chan K., Chukwuenweniwe C., Johnson R., Khair D., Duck E., Olubodun O., Barwick K., Banya W., et al. Comparison of Lymphocyte-CRP Ratio to Conventional Inflammatory Markers for Predicting Clinical Outcomes in COVID-19. J. Pers. Med. 2023;13:909. doi: 10.3390/jpm13060909. - DOI - PMC - PubMed